Product Program year 2020 Source: CMS Open Payments

Mk-7075

Drug Oncology

Open in the dashboard

General payments

$18,078

28 payments

Research payments

$628,772

28 payments

Through program year 2020, $18,078 in general payments and $628,772 in research payments were reported against Mk-7075 (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $18,078 28
2020 Research $628,772 28

Breakdown

Who paid General payments · program year 2020
  1. Merck Sharp & Dohme Corporation $18,078 28 payments
Top recipients General payments · program year 2020
  1. Adrienne Hammill Pediatric Hematology-Oncology · Cincinnati, OH $2,023 11% · 3 payments
  2. Josue Flores Daboub Clinical Genetics (M.D.) · Peoria, IL $2,019 11% · 3 payments
  3. Michael Jeng Pediatric Hematology-Oncology · Palo Alto, CA $1,982 11% · 3 payments
  4. Ionela Iacobas Pediatrics · Houston, TX $1,964 11% · 3 payments
  5. William Dobyns Clinical Genetics (M.D.) · Chicago, IL $1,961 11% · 3 payments

The top 5 of 10 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Pediatric Hematology-Oncology Pediatrics $5,898 33% · 3 practitioners
  2. Clinical Genetics (M.D.) Medical Genetics $3,979 22% · 2 practitioners
  3. Pediatrics $1,964 11% · 1 practitioner
  4. Pediatric Otolaryngology Otolaryngology $1,936 11% · 1 practitioner
  5. Endocrinology, Diabetes & Metabolism Internal Medicine $1,935 11% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Illinois $3,979 22% · 2 recipients
  2. Wisconsin $2,435 13% · 2 recipients
  3. Ohio $2,023 11% · 1 recipient
  4. California $1,982 11% · 1 recipient
  5. New Jersey $1,964 11% · 1 recipient

The top 5 of 8 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

28 general · 28 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record